Free Trial
OTCMKTS:NWBO

Northwest Biotherapeutics (NWBO) Stock Price, News & Analysis

Northwest Biotherapeutics logo
$0.24 +0.01 (+2.82%)
As of 03:59 PM Eastern

About Northwest Biotherapeutics Stock (OTCMKTS:NWBO)

Key Stats

Today's Range
$0.23
$0.25
50-Day Range
$0.22
$0.28
52-Week Range
$0.17
$0.48
Volume
1.08 million shs
Average Volume
3.27 million shs
Market Capitalization
$363.79 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Northwest Biotherapeutics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
11th Percentile Overall Score

NWBO MarketRank™: 

Northwest Biotherapeutics scored higher than 11% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Northwest Biotherapeutics.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Northwest Biotherapeutics is -4.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Northwest Biotherapeutics is -4.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    3.64% of the float of Northwest Biotherapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Northwest Biotherapeutics has a short interest ratio ("days to cover") of 9.2.
  • Change versus previous month

    Short interest in Northwest Biotherapeutics has recently decreased by 0.79%, indicating that investor sentiment is improving.
  • Dividend Yield

    Northwest Biotherapeutics does not currently pay a dividend.

  • Dividend Growth

    Northwest Biotherapeutics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.64% of the float of Northwest Biotherapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Northwest Biotherapeutics has a short interest ratio ("days to cover") of 9.2.
  • Change versus previous month

    Short interest in Northwest Biotherapeutics has recently decreased by 0.79%, indicating that investor sentiment is improving.
  • News Sentiment

    Northwest Biotherapeutics has a news sentiment score of 0.68. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.50 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Northwest Biotherapeutics this week, compared to 0 articles on an average week.
  • Search Interest

    4 people have searched for NWBO on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • MarketBeat Follows

    5 people have added Northwest Biotherapeutics to their MarketBeat watchlist in the last 30 days. This is an increase of 150% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Northwest Biotherapeutics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 8.70% of the stock of Northwest Biotherapeutics is held by insiders.

  • Percentage Held by Institutions

    Only 0.04% of the stock of Northwest Biotherapeutics is held by institutions.

  • Read more about Northwest Biotherapeutics' insider trading history.
Receive NWBO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Northwest Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter.

NWBO Stock News Headlines

GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. Backed by the government but powered by private corporations, this initiative paves the way for digital dollars—programmable, trackable, and outside your control. Once embedded into apps, banks, and retail systems, opting out may no longer be possible. But there’s still time to protect your financial freedom—if you act before the system goes fully live.tc pixel
Northwest Biotherapeutics, Inc. (NWBO) - Yahoo Finance
NWBO Northwest Biotherapeutics, Inc. - Seeking Alpha
See More Headlines

NWBO Stock Analysis - Frequently Asked Questions

Northwest Biotherapeutics' stock was trading at $0.2748 at the beginning of 2025. Since then, NWBO shares have decreased by 9.9% and is now trading at $0.2477.

Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO) announced its quarterly earnings data on Thursday, August, 14th. The biotechnology company reported ($0.01) earnings per share (EPS) for the quarter. The biotechnology company earned $0.13 million during the quarter.

Shares of NWBO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Northwest Biotherapeutics investors own include Clearside Biomedical (CLSD), Ocular Therapeutix (OCUL), Melinta Therapeutics (MLNT), NVIDIA (NVDA), Intel (INTC), Advanced Micro Devices (AMD) and Meta Platforms (META).

Company Calendar

Last Earnings
8/14/2025
Today
8/21/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:NWBO
Previous Symbol
NASDAQ:NWBO
CIK
1072379
Employees
20
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.06)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$83.78 million
Net Margins
-7,524.50%
Pretax Margin
-7,524.50%
Return on Equity
N/A
Return on Assets
-291.13%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.07
Quick Ratio
0.06

Sales & Book Value

Annual Sales
$1.38 million
Price / Sales
258.77
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.07) per share
Price / Book
-3.43

Miscellaneous

Outstanding Shares
1,486,660,000
Free Float
1,353,382,000
Market Cap
$357.10 million
Optionable
Not Optionable
Beta
-1.14

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (OTCMKTS:NWBO) was last updated on 8/21/2025 by MarketBeat.com Staff
From Our Partners